Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 27Unknown 9Recruiting 4Terminated 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 1127Neoplasms 982Carcinoma, Non-Small-Cell Lung 900Prostatic Neoplasms 594Neoplasm Metastasis 528Leukemia, Myeloid, Acute 513Colorectal Neoplasms 491Lung Neoplasms 487Melanoma 485Multiple Myeloma 477Pancreatic Neoplasms 385Lymphoma 369Ovarian Neoplasms 368Recurrence 365Lymphoma, Non-Hodgkin 346Leukemia 339Leukemia, Lymphocytic, Chronic, B-Cell 321Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Head and Neck Neoplasms 276Carcinoma, Renal Cell 276Brain Neoplasms 273Carcinoma, Hepatocellular 261Glioblastoma 249Lymphoma, Large B-Cell, Diffuse 244Myelodysplastic Syndromes 242Squamous Cell Carcinoma of Head and Neck 241Lymphoma, Follicular 236Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190

Interventions

Gemcitabine 1Fondaparinux 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Thromboembolism × Clear all
NCT00423683 2016-06-08

Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism

Northwell Health

Phase 3 Terminated
64 enrolled 9 charts

Neoplasms, Thromboembolism

NCT00031837 2015-10-14

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

University of Rochester

Phase 3 Terminated
400 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT00662688 2013-03-13

PAM07

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated
42 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡